AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (3.8 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review Article | Open Access | Online First

Drug-induced liver injury therapy: unveiling the healing potential of natural products from medicinal and food homology plants

Xi-Yue Tan1,Tao Jiang1,Qi-Chao Hu1Yuan-Ping Hai2,3Xiao-Hua Lu2Chun-Mei Jin2Xiao Ma1( )Ye-Yu Li4( )Thomas Efferth2( )
Chinese Medicine Germplasm Resources Innovation and Effective Uses Key Laboratory of Sichuan Province, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Mainz 55128, Germany
Department of Endocrinology and Metabolism, Shunde Hospital, Southern Medical University (The First People’s Hospital of Shunde), Foshan 528308, China
TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China

Xi-Yue Tan and Tao Jiang contributed equally to this work.

Show Author Information

Highlights

(1) Comprehensive review: the article provides a comprehensive review of the therapeutic mechanisms of medicinal natural products in DILI therapy, covering a wide range of potential mechanisms and clinical studies.

(2) Focus on polyphenolic natural products: it highlights the therapeutic role of polyphenolic compounds from medicinal and edible plants, emphasising their potential in the development of new drugs for the treatment of DILI.

(3) Molecular mechanisms: The molecular mechanisms by which these natural products alleviate liver injury are explored in depth, including inhibition of oxidative stress and inflammation, activation of antioxidant defences, and modulation of gut flora, endoplasmic reticulum stress, mitochondrial stress, and autophagy.

(4) Safety and side effects: The article discusses the safety and side effects of DILI therapy with Chinese medicinal and food-based natural products, which is critical for their clinical application and future drug development.

(5) Personalised therapeutic pathways: recognising the need for personalised therapeutic pathways due to the heterogeneity of the patient population, it is implied that pharmacophagic natural products can provide a more customised and comprehensive health management plan.

Abstract

Drug induced liver injury (DILI) is an important adverse reaction caused by the use of drugs in clinical practice. In severe cases, it can even pose a threat to life. The commonly reported drugs that cause DILI include non-steroidal anti-inflammatory drugs, antibiotics, and anti-cancer drugs, etc. In recent years, a large number of studies have shown that medicinal and edible plants with their natural products have demonstrated great potential in the treatment of DILI. In animal models, these substances can alleviate DILI by inhibiting oxidative stress and inflammatory responses, activating the antioxidant defense system, regulating the intestinal flora, alleviating endoplasmic reticulum and mitochondrial stress, and regulating autophagy, among other pathways. Furthermore, natural compounds such as glycyrrhizic acid, and silymarin have already shown preliminary improvement effects on DILI in clinical practice. However, it is worth noting that in cases of improper assessment, unreasonable use, or other circumstances, these natural substances can also potentially cause or exacerbate liver damage. Therefore, it is necessary to conduct further assessment of the safety range and potential side effects of the drug during the clinical drug development and application process. Overall, the medicinal and edible plants with their natural products provide new strategies and resources for the prevention and treatment of DILI as well as for drug development.

Graphical Abstract

Natural products from medicinal and food homology plants (e.g., wolfberry, green tea) exert hepatoprotective effects by modulating multiple pathways: reducing oxidative stress via Nrf2 activation, suppressing inflammation, activating autophagy, alleviating ER stress, and protecting mitochondria. They also regulate gut microbiota to mitigate drug-induced liver toxicity. These mechanisms collectively promote liver repair and reduce cellular damage. Preclinical studies support their potential, particularly in chemotherapy-induced DILI, though further research is needed to confirm long-term clinical safety and efficacy.

References

【1】
【1】
 
 
Food & Medicine Homology

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Tan X-Y, Jiang T, Hu Q-C, et al. Drug-induced liver injury therapy: unveiling the healing potential of natural products from medicinal and food homology plants. Food & Medicine Homology, 2026, https://doi.org/10.26599/FMH.2026.9420140

1544

Views

181

Downloads

0

Crossref

0

Web of Science

Received: 31 August 2024
Revised: 20 September 2024
Accepted: 05 October 2024
Published: 10 March 2026
© National R & D Center for Edible Fungus Processing Technology 2026. Published by Tsinghua University Press.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).